Search PubMed⌕ Search

PubMed · 9739276

Pharmacology: impact on bladder function.

Abstract

While numerous medications are effective in improving bladder function, others are implicated in the impairment of bladder function. The elderly patient in particular is vulnerable to a range of adverse effects from medications, including urinary incontinence. Information dealing with the basics of the interaction between voiding and drug receptors associated with the bladder is presented as background for the discussion of pharmacologic therapies for stress, urge, reflex, and overflow urinary incontinence. The most clinically significant medications in terms of effectiveness, dosage, pharmacokinetics, and side effects are noted with mention of drugs currently being researched. Over-the-counter, prescription and social drugs that may contribute to impaired bladder function are identified. Other nonpharmacologic therapies that may be used concomitantly with pharmacotherapy or in isolation are noted.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K N Moore, V A Richardson. 1998. Pharmacology: impact on bladder function.. https://pubmed.ncbi.nlm.nih.gov/9739276/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Anticholinergic drugs in patients with bladder outlet obstruction and lower urinary tract symptoms: A systematic review.

OBJECTIVES: To review the available evidence concerning the use of anticholinergic drugs, alone or in combination with alpha-blockers, in patients with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) and concomitant overactive bladder syndrome, to assess whether the currently available evidence suggests a role for antimuscarinic drugs in patients with BPH. METHODS: A systematic review of the literature was performed using Embase, MEDLINE, and Web of Science through a complex search strategy including "free text" and "MeSH" protocols. Moreover, the Cochrane database of systematic review was browsed for records regarding BPH and the abstract books of the American Urological Association, European Association of Urology, and International Continence Society annual meetings from 2000 to 2005 were hand-searched for studies concerning the topic of the review. RESULTS: From the literature search, we identified four randomised controlled trials (RCTs), two prospective case series, and a few congress abstracts. For methodologic issues, the best RCT was based on urodynamic data, but did not provide any clinical insight on the patients' symptoms. The other papers were affected by significant methodologic or clinical drawbacks. CONCLUSION: The available data may be considered promising in terms of safety and efficacy. The evidence of the limited number of RCTs available, considering their methodologic or clinical shortcomings, is not sufficient to support the clinical use of combination therapy with alpha-blockers and anticholinergic drugs in patients with associated storage and voiding symptoms. Well-designed, large, double-blind, placebo-controlled, long-term RCTs are needed to assess the long-term safety and efficacy of antimuscarinic drugs, alone or in combination with alpha-blockers, in this category of patients.

Cholinergic Antagonists↗